Jacob Steven Leach - 28 Jan 2025 Form 4 Insider Report for DEXCOM INC (DXCM)

Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Jacob Steven Leach
Issuer symbol
DXCM
Transactions as of
28 Jan 2025
Transactions value $
-$228,932
Form type
4
Filing time
30 Jan 2025, 18:44:07 UTC
Previous filing
17 Dec 2024
Next filing
11 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0 +7.11K +2.69% $0.00 271K 28 Jan 2025 Direct F1, F2
transaction DXCM Common Stock Sale -$229K -2.63K -0.97% $86.91 269K 29 Jan 2025 Direct F2, F3
holding DXCM Common Stock 47.3K 28 Jan 2025 Family Holdings F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2022 that vested on January 28, 2025.
F2 Included in this number are 51,972 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 16,931 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 8,988 of which were granted on March 8, 2022 and shall vest through March 8, 2025.
F3 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F4 Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.